For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the Wisconsin man's death in 2024.
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...
Diagnosed with asthma as a baby, Cole Schmidtknecht took the inhaler daily as a preventive medication since he was about 13, ...
United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Pharmacists are praising a bill under consideration in the Iowa House and Senate that would set new restrictions on pharmacy ...